For each drug an ANOVA model was fitted to correlate drug response with the status of Cancer Functional Events (CFEs), as described in Garnett et al. (2012) (link), implemented in GDSCtools (http//gdsctools.readthedocs.io) and detailed in the the Supplemental Experimental Procedures. The downsampling ANOVA simulation studies are detailed in the Supplemental Experimental Procedures. We applied the LOBICO (Knijnenburg et al., 2016 ) framework as detailed in the Supplemental Experimental Procedures. Machine learning models were computed as detailed in the Supplemental Experimental Procedures.
Free full text: Click here